Correlation Between Biotechnology Assets and Labiana Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Assets and Labiana Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Assets and Labiana Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Assets SA and Labiana Health SA, you can compare the effects of market volatilities on Biotechnology Assets and Labiana Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Assets with a short position of Labiana Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Assets and Labiana Health.

Diversification Opportunities for Biotechnology Assets and Labiana Health

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Biotechnology and Labiana is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Assets SA and Labiana Health SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Labiana Health SA and Biotechnology Assets is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Assets SA are associated (or correlated) with Labiana Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Labiana Health SA has no effect on the direction of Biotechnology Assets i.e., Biotechnology Assets and Labiana Health go up and down completely randomly.

Pair Corralation between Biotechnology Assets and Labiana Health

Assuming the 90 days trading horizon Biotechnology Assets SA is expected to generate 2.07 times more return on investment than Labiana Health. However, Biotechnology Assets is 2.07 times more volatile than Labiana Health SA. It trades about 0.14 of its potential returns per unit of risk. Labiana Health SA is currently generating about -0.2 per unit of risk. If you would invest  28.00  in Biotechnology Assets SA on August 28, 2024 and sell it today you would earn a total of  6.00  from holding Biotechnology Assets SA or generate 21.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Biotechnology Assets SA  vs.  Labiana Health SA

 Performance 
       Timeline  
Biotechnology Assets 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Assets SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Biotechnology Assets exhibited solid returns over the last few months and may actually be approaching a breakup point.
Labiana Health SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Labiana Health SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Biotechnology Assets and Labiana Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Assets and Labiana Health

The main advantage of trading using opposite Biotechnology Assets and Labiana Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Assets position performs unexpectedly, Labiana Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Labiana Health will offset losses from the drop in Labiana Health's long position.
The idea behind Biotechnology Assets SA and Labiana Health SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets